MOTHERISK ROUNDS: Cocaine Abuse During Pregnancy

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 7, 2014, Pages 628-631

  Cressman, Alex M ^a,b   Natekar, Aniket ^a   Kim, Eunji ^a   Koren, Gideon ^a,b   Bozzo, Pina ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cocaine; Pregnancy; Teratogenicity

Indexed keywords

COCAINE;

ARTICLE; BEHAVIOR DISORDER; COCAINE DEPENDENCE; COGNITIVE DEFECT; DEMOGRAPHY; DEVELOPMENTAL LANGUAGE DISORDER; DISEASE ASSOCIATION; DRUG ABUSE; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MEMORY DISORDER; PATIENT COUNSELING; PLACENTA DISORDER; PLACENTAL INFARCTION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; SOLUTIO PLACENTAE; COMPLICATION; FEMALE; PREGNANCY COMPLICATION;

COCAINE-RELATED DISORDERS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84922276288     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30543-0     Document Type: Article

References (39)

1. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
2. Behnke M., Smith V.C. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 2013, 131(3):e1009-e1024.
3. Chasnoff I.J., Burns W.J., Schnoll S.H., Burns K.A. Cocaine use in pregnancy. N Engl J Med 1985, 313(11):666-669.
4. Bingol N., Fuchs M., Diaz V., Stone R.K., Gromisch D.S. Teratogenicity of cocaine in humans. J Pediatr 1987, 110(1):93-96.
5. Bhargava S., Arora R.R. Cocaine and cardiovascular complications. Am J Ther 2011, 18(4):e95-e100.
6. Glauser J., Queen J.R. An overview of non-cardiac cocaine toxicity. J Emerg Med 2007, 32(2):181-186.
7. Ostrea E.M., Brady M., Gause S., Raymundo A.L., Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992, 89(1):107-113.
8. Pichini S., Puig C., Zuccaro P., Marchei E., Pellegrini M., Murillo J., et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project.". Forensic science international 2005, 153(1):59-65.
9. Forman R., Klein J., Barks J., Mehta D., Greenwald M., Einarson T., et al. Prevalence of fetal exposure to cocaine in Toronto, 1990-1991. Clin invest Med 1994, 17(3):206-211.
10. Finer L.B., Zolna M.R. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011, 84(5):478-485.
11. Schenker S., Yang Y., Johnson R.F., Downing J.W., Schenken R.S., Henderson G.I., et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993, 53(3):329-339.
12. Benveniste H., Fowler J.S., Rooney W.D., Scharf B.A., Backus W.W., Izrailtyan I., et al. Cocaine is pharmacologically active in the nonhuman primate fetal brain. Proc Natl Acad Sci U S A 2010, 107(4):1582-1587.
13. Bendersky M., Alessandri S., Gilbert P., Lewis M. Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse 1996, 22(3):349-362.
14. Bauer C.R., Shankaran S., Bada H.S., Lester B., Wright L.L., Krause-Steinrauf H., et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002, 186(3):487-495.
15. Richardson G.A., Goldschmidt L., Larkby C. Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics 2007, 120(4):e1017-e1027.
16. Bada H.S., Bann C.M., Whitaker T.M., Bauer C.R., Shankaran S., Lagasse L., et al. Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures. Pediatrics 2012, 130(6):e1479-e1488.
17. Nair P., Schuler M.E., Black M.M., Kettinger L., Harrington D. Cumulative environmental risk in substance abusing women: early intervention, parenting stress, child abuse potential and child development. Child Abuse Negl 2003, 27(9):997-1017.
18. Bada H.S., Das A., Bauer C.R., Shankaran S., Lester B., Wright L.L., et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002, 100(5 Pt 1):916-924.
19. Lambert B.L., Bauer C.R. Developmental and behavioral consequences of prenatal cocaine exposure: a review. J Perinatol 2012, 32(11):819-828.
20. Gouin K., Murphy K., Shah P.S. Knowledge Synthesis group on Determinants of Low Birth Weight and Preterm Births. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011, 204(4):e1-e12. 340.
21. Addis A., Moretti M.E., Ahmed Syed F., Einarson T.R., Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001, 15(4):341-369.
22. Mbah A.K., Alio A.P., Fombo D.W., Bruder K., Dagne G., Salihu H.M. Association between cocaine abuse in pregnancy and placenta-associated syndromes using propensity score matching approach. Early Hum Dev 2012, 88(6):333-337.
23. Ness R.B., Grisso J.A., Hirschinger N., Markovic N., Shaw L.M., Day N.L., et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999, 340(5):333-339.
24. Lutiger B., Graham K., Einarson T.R., Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology 1991, 44(4):405-414.
25. Bauchner H., Zuckerman B., Amaro H., Frank D.A., Parker S. Teratogenicity of cocaine. J Pediatr 1987, 111(1):160-161.
26. Koren G. Cocaine and the human fetus: the concept of teratophilia. Neurotoxicol Teratol 1993, 15(5):301-304. discussion 11-2.
27. Behnke M., Eyler F.D., Garvan C.W., Wobie K. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 2001, 107(5):E74.
28. Minnes S., Robin N.H., Alt A.A., Kirchner H.L., Satayathum S., Salbert B.A., et al. Dysmorphic and anthropometric outcomes in 6-year-old prenatally cocaine-exposed children. Neurotoxicol Teratol 2006, 28(1):28-38.
29. Covington C.Y., Nordstrom-Klee B., Ager J., Sokol R., Delaney-Black V. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study. Neurotoxicol Teratol 2002, 24(4):489-496.
30. Buckingham-Howes S., Berger S.S., Scaletti L.A., Black M.M. Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 2013, 131(6):e1917-e1936.
31. Singer L.T., Nelson S., Short E., Min M.O., Lewis B., Russ S., et al. Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 2008, 153(1):105-111.
32. Mayes L., Snyder P.J., Langlois E., Hunter N. Visuospatial working memory in school-aged children exposed in utero to cocaine. Child Neuropsychol 2007, 13(3):205-218.
33. Bada H.S., Das A., Bauer C.R., Shankaran S., Lester B., LaGasse L., et al. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 2007, 119(2):e348-e359.
34. Linares T.J., Singer L.T., Kirchner H.L., Short E.J., Min M.O., Hussey P., et al. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006, 31(1):85-97.
35. Betancourt L.M., Yang W., Brodsky N.L., Gallagher P.R., Malmud E.K., Giannetta J.M., et al. Adolescents with and without gestational cocaine exposure: longitudinal analysis of inhibitory control, memory and receptive language. Neurotoxicol Teratol 2011, 33(1):36-46.
36. Landi N., Crowley M.J., Wu J., Bailey C.A., Mayes L.C. Deviant ERP response to spoken non-words among adolescents exposed to cocaine in utero. Brain Lang 2012, 120(3):209-216.
37. Nulman I., Rovet J., Greenbaum R., Loebstein M., Wolpin J., Pace-Asciak P., et al. Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study. Clin Invest Med 2001, 24(3):129-137.
38. Ackerman J.P., Riggins T., Black M.M. A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 2010, 125(3):554-565.
39. Frank D.A., Augustyn M., Knight W.G., Pell T., Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001, 285(12):1613-1625.